These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33438331)

  • 41. Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.
    Weinstein SF; Katial RK; Bardin P; Korn S; McDonald M; Garin M; Bateman ED; Hoyte FCL; Germinaro M
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):589-596.e3. PubMed ID: 30193936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Nasal provocation with increased ASA dose: improved "non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated disease" (N‑ERD) detection rate in chronic rhinosinusitis patients].
    Förster-Ruhrmann U; Behrbohm W; Pierchalla G; Szczepek AJ; Fluhr JW; Olze H
    HNO; 2019 Aug; 67(8):620-627. PubMed ID: 31069402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Type 2 biologics reduce cumulative steroid exposure in aspirin-exacerbated respiratory disease.
    Ghiasi Y; Wangberg H; Bagsic SRS; White A
    Ann Allergy Asthma Immunol; 2022 Nov; 129(5):642-643. PubMed ID: 35908738
    [No Abstract]   [Full Text] [Related]  

  • 44. Topical nasal lysine aspirin in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis with nasal polyposis.
    Parikh A; Scadding GK
    Expert Rev Clin Immunol; 2014 May; 10(5):657-65. PubMed ID: 24684687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Samter's Triad to Aspirin-Exacerbated Respiratory Disease: Historical Perspective and Current Clinical Practice.
    Krouse HJ; Krouse JH
    ORL Head Neck Nurs; 2015; 33(4):14-8. PubMed ID: 26753248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Asthma exacerbation due to preoperative NSAID use].
    Miry T; van der Sar-van der Brugge S; van der Rijt AJM
    Ned Tijdschr Geneeskd; 2021 Mar; 165():. PubMed ID: 33720565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
    Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
    Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aspirin-exacerbated respiratory disease: longitudinal assessment of a large cohort and implications of diagnostic delay.
    Kshirsagar RS; Chou DW; Wei J; Liang J
    Int Forum Allergy Rhinol; 2020 Apr; 10(4):465-473. PubMed ID: 32104978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspirin-Exacerbated Respiratory Disease With Allergic Fungal Rhinosinusitis: A Case Series of Overlapping Sinonasal Endotypes.
    Studer MB; Roland LT; Ochsner MC; Cox D; DelGaudio JM; Wise SK; Levy JM
    Am J Rhinol Allergy; 2020 May; 34(3):422-427. PubMed ID: 32036687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does it make sense to "desens"? Aspirin desensitization in the treatment of chronic rhinosinusitis.
    Lee JY; Simon RA
    Curr Allergy Asthma Rep; 2006 May; 6(3):183-4. PubMed ID: 16579867
    [No Abstract]   [Full Text] [Related]  

  • 51. Dupilumab-associated arthralgia in patients with aspirin-exacerbated respiratory disease.
    Miss Ozuna L; Ryan T; Bensko JC; Laidlaw TM; Buchheit KM
    Ann Allergy Asthma Immunol; 2022 Apr; 128(4):469-472. PubMed ID: 35124224
    [No Abstract]   [Full Text] [Related]  

  • 52. Comorbid diseases in aspirin-exacerbated respiratory disease, and asthma.
    Erdogan T; Karakaya G; Kalyoncu AF
    Allergol Immunopathol (Madr); 2015; 43(5):442-8. PubMed ID: 25547458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease - a randomized crossover trial.
    Sowerby LJ; Patel KB; Schmerk C; Rotenberg BW; Rocha T; Sommer DD
    J Otolaryngol Head Neck Surg; 2021 Apr; 50(1):27. PubMed ID: 33892819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inheritance of NSAID-Exacerbated Respiratory Disease.
    Suikkila A; Lyly A; Hafrén L; Saarinen R; Klockars T
    Otolaryngol Head Neck Surg; 2023 Mar; 168(3):540-543. PubMed ID: 35639475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic Rhinosinusitis.
    Trikha A; Kingdom T
    J Allergy Clin Immunol Pract; 2015; 3(5):821-2; quiz 823. PubMed ID: 26362554
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunomodulatory treatments for aspirin exacerbated respiratory disease.
    Moebus RG; Han JK
    Am J Rhinol Allergy; 2012; 26(2):134-40. PubMed ID: 22487291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eosinophilic asthma with nasal polyposis march: Is aspirin-exacerbated respiratory disease the last station?
    Yılmaz İ; Türk M; Bahçecioğlu SN
    J Allergy Clin Immunol Pract; 2017; 5(6):1807-1808. PubMed ID: 29122169
    [No Abstract]   [Full Text] [Related]  

  • 58. Aspirin or Nonsteroidal Anti-inflammatory Drug-Exacerbated Chronic Rhinosinusitis.
    Ledford DK; Lockey RF
    J Allergy Clin Immunol Pract; 2016; 4(4):590-8. PubMed ID: 27393773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Comparison of Sphenoid Sinus Osteoneogenesis in Aspirin-Exacerbated Respiratory Disease.
    Malfitano MJ; Santarelli GD; Gelpi M; Brown WC; Stepp WH; Hernandez S; Kimple AJ; Thorp BD; Zanation AM; Ebert CS
    Am J Rhinol Allergy; 2021 Mar; 35(2):172-178. PubMed ID: 32660262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An update on the pathogenesis of the upper airways in aspirin-exacerbated respiratory disease.
    Choi JH; Kim MA; Park HS
    Curr Opin Allergy Clin Immunol; 2014 Feb; 14(1):1-6. PubMed ID: 24300420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.